Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine.

Tanabe J, Crowley T, Hutchison K, Miller D, Johnson G, Du YP, Zerbe G, Freedman R.

Neuropsychopharmacology. 2008 Feb;33(3):627-33. Epub 2007 Apr 25.

2.
3.

High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.

Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB.

Exp Clin Psychopharmacol. 2007 Feb;15(1):81-92.

PMID:
17295587
4.

Effects of varenicline on smoking cue–triggered neural and craving responses.

Franklin T, Wang Z, Suh JJ, Hazan R, Cruz J, Li Y, Goldman M, Detre JA, O'Brien CP, Childress AR.

Arch Gen Psychiatry. 2011 May;68(5):516-26. doi: 10.1001/archgenpsychiatry.2010.190. Epub 2011 Jan 3.

5.

Enhanced dopamine transporter function in striatum during nicotine withdrawal.

Hadjiconstantinou M, Duchemin AM, Zhang H, Neff NH.

Synapse. 2011 Feb;65(2):91-8. doi: 10.1002/syn.20820.

PMID:
20506223
6.

Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain.

Cumming P, Rosa-Neto P, Watanabe H, Smith D, Bender D, Clarke PB, Gjedde A.

Neuroimage. 2003 Jul;19(3):1127-36.

PMID:
12880838
7.

Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers.

Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA, Zubieta JK.

Synapse. 2000 Dec 1;38(3):313-21.

8.

Rodent models of nicotine withdrawal syndrome.

Malin DH, Goyarzu P.

Handb Exp Pharmacol. 2009;(192):401-34. doi: 10.1007/978-3-540-69248-5_14. Review.

PMID:
19184657
9.

Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.

Rose JE, Behm FM, Westman EC.

Pharmacol Biochem Behav. 2001 Feb;68(2):187-97.

PMID:
11267622
10.

Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.

Leischow SJ, Valente SN, Hill AL, Otte PS, Aickin M, Holden T, Kligman E, Cook G.

Exp Clin Psychopharmacol. 1997 Feb;5(1):54-64.

PMID:
9234040
11.

Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics.

Cole DM, Beckmann CF, Long CJ, Matthews PM, Durcan MJ, Beaver JD.

Neuroimage. 2010 Aug 15;52(2):590-9. doi: 10.1016/j.neuroimage.2010.04.251. Epub 2010 May 2.

PMID:
20441798
12.

FKBP5 variation is associated with the acute and chronic effects of nicotine.

Jensen KP, Herman AI, Morean ME, Kranzler HR, Gelernter J, Sofuoglu M.

Pharmacogenomics J. 2015 Aug;15(4):340-6. doi: 10.1038/tpj.2014.76. Epub 2014 Dec 23.

13.

Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling.

Addicott MA, Froeliger B, Kozink RV, Van Wert DM, Westman EC, Rose JE, McClernon FJ.

Neuropsychopharmacology. 2014 Nov;39(12):2750-9. doi: 10.1038/npp.2014.108. Epub 2014 May 13.

14.

Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.

Myers CS, Taylor RC, Moolchan ET, Heishman SJ.

Neuropsychopharmacology. 2008 Feb;33(3):588-98. Epub 2007 Apr 18.

15.

Do adolescent smokers experience withdrawal effects when deprived of nicotine?

Killen JD, Ammerman S, Rojas N, Varady J, Haydel F, Robinson TN.

Exp Clin Psychopharmacol. 2001 May;9(2):176-82.

PMID:
11518093
16.

The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.

Beaver JD, Long CJ, Cole DM, Durcan MJ, Bannon LC, Mishra RG, Matthews PM.

Neuropsychopharmacology. 2011 Aug;36(9):1792-800. doi: 10.1038/npp.2011.53. Epub 2011 May 4.

17.

Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence.

Muramoto ML, Ranger-Moore J, Leischow SJ.

Nicotine Tob Res. 2003 Apr;5(2):223-30.

PMID:
12745495
18.

Effects of chronic nicotine administration and its withdrawal on striatal FosB/DeltaFosB and c-Fos expression in rats and mice.

Marttila K, Raattamaa H, Ahtee L.

Neuropharmacology. 2006 Jul;51(1):44-51. Epub 2006 Apr 24.

PMID:
16631212
19.

The role of nicotine on respiratory sensory gating measured by respiratory-related evoked potentials.

Chan PY, Davenport PW.

J Appl Physiol (1985). 2010 Mar;108(3):662-9. doi: 10.1152/japplphysiol.00798.2009. Epub 2010 Jan 7.

20.

The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.

Jackson KJ, McIntosh JM, Brunzell DH, Sanjakdar SS, Damaj MI.

J Pharmacol Exp Ther. 2009 Nov;331(2):547-54. doi: 10.1124/jpet.109.155457. Epub 2009 Jul 30.

Supplemental Content

Support Center